Evidence map›Paper›PMID 24463225›Full record

ReviewCurrent opinion in obstetrics & gynecology2014

Antenatal steroids: can we optimize the dose?

Ewa Romejko-Wolniewicz, Justyna Teliga-Czajkowska, Krzysztof Czajkowski

Open access · hybridAbstract readReview
In one paragraph

Review in Current opinion in obstetrics & gynecology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Ewa Romejko-Wolniewicza2nd Department of Obstetrics and Gynecology bDepartment of Didactics of Gynecology and Obstetrics, Medical University of Warsaw, Warsaw, Poland.
Justyna Teliga-Czajkowska
Krzysztof Czajkowski
GTx (United States) · USMedical University of Warsaw · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewThe beneficial effects of antenatal steroids in women at risk of preterm birth are evident. A dose of 24 mg appears sufficient, but there are insufficient data to recommend betamethasone or dexamethasone, a single steroid dose, the optimal interval between doses and repeated courses, the gestational age at which treatment is beneficial and the long-term effects of steroid treatment. This review addresses these aspects of antenatal steroid treatment. RECENT

findingsAlthough the 12-h and 24-h dosing intervals are equivalent with respect to prevention of respiratory distress syndrome, the former enables the completion of treatment in 50% more neonates delivered prematurely. Reducing the single steroid dose in patients at risk for premature birth reduces the associated maternal side effects. An inverse relationship has been demonstrated between the number of corticosteroid courses and foetal growth. The reduced size of exposed foetuses has been attributed to birth at earlier gestational ages and decreased foetal growth. Evidence suggests that antenatal exposure to synthetic glucocorticoids in term-born children has long-lasting effects, which may have important implications in the recommendation of steroids before elective caesarean at term. SUMMARY: The short-term and long-term effects of the dosage regimen on the pregnant mother and foetus remain unclear.

Indexed as

Anti-Inflammatory AgentsBetamethasoneDexamethasoneDose-Response Relationship, DrugDrug Administration ScheduleFemaleFetal DevelopmentGestational AgeGlucocorticoidsHumansInfant, NewbornPractice Guidelines as TopicPregnancyPregnancy OutcomePremature BirthRespiratory Distress Syndrome, NewbornAnti-Inflammatory AgentsBetamethasoneDexamethasoneGlucocorticoids

Identifiers

PMID24463225
PMCPMC3966924
OpenAlexW2004795895

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.